Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Fall;4(4):781-4.

Comparative study on toxoplasma serology among HIV positive and HIV negative illicit drug users in Ahvaz, Iran

Affiliations

Comparative study on toxoplasma serology among HIV positive and HIV negative illicit drug users in Ahvaz, Iran

Seyed Mohammad Alavi et al. Caspian J Intern Med. 2013 Fall.

Abstract

Background: Toxoplasmosis is a common parasitic infection in human around the world and can cause life-threatening encephalitis in human immunodeficiency virus (HIV) infected host. The aim of this study was to assess the frequency of toxoplasma infection in illicit drug users (IDUs) with and without HIV infection in Iran.

Methods: This study was carried out on 84 IDUs (42 HIV positive as case group and 42 HIV negative subjects as control group) from 2008 to 2009. Serum samples were tested for T. gondii IgG antibodies by Enzym linked immunosorbant assay (ELISA). Based on the company brochure kit, the test was defined positive if the antibody titer was 3 IU/ml or more. The data from these two groups were collected and analyzed.

Results: The mean age of HIV positive cases was 34.4±8.6 and for HIV negative cases was 35.9±9.3 year. The mean age and distribution of sex in both groups were equal. The frequency of toxoplasma-IgG in HIV positive and HIV negative was 73.8% and 81%, respectively (p=0.19).

Conclusion: The results show that prevalence of toxoplasmosis infection in the illicit drug users with HIV positive or negative is equal.

Keywords: HIV; Illicit drug user.; Toxoplasma antibody.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean±SD antibodies titer of IgG in HIV positive and HIV negative studied cases

References

    1. Montoya JG, Kovacs JA, Remington JS. Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone ; 2012. pp. 3495–510.
    1. McCabe RE, Remington JS. Toxoplasmosis: The time has now come. N Engl J Med. 1988;318:313–5. - PubMed
    1. Jones JL, Kruszon-Moran D, Wilson M, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 2001;154:357–65. - PubMed
    1. Jeannel D, Niel G, Costagliola D, et al. Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol. 1988;17:595–602. - PubMed
    1. Ghorbani M, Edrisian GH, Asad N. Serological survey of toxoplasmosis in the northern part of Iran, using indirect fluorescent antibody technique. Trans R Soc Trop Med Hyg. 1978;72:369–71. - PubMed

LinkOut - more resources